Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that the Company is organising Investor and Analyst Meet on June 18, 2021. Details of the same are attached.
The above information is a part of company’s filings submitted to BSE.